论文部分内容阅读
目的比较国产尿促卵泡素(u FSH)和瑞士产人重组促卵泡激素(r FSH)治疗不孕症临床疗效。方法 107例不孕症患者,按照随机数字表法分为A、B两组,A组54例,应用u FSH治疗,B组53例,应用r FSH治疗,比较两组治疗有效率、排卵率、妊娠率、卵巢过度刺激综合征(OHSS)发生率。结果 A、B组治疗有效率分别为98.1%、100.0%,差异无统计学意义(P>0.05)。排卵率、妊娠率、OHSS发生率比较差异无统计学意义(P>0.05)。结论国产尿促卵泡素为理想促排卵药,效果与瑞士产人重组促卵泡激素相当,但经济性更高,值得临床应用推广。
Objective To compare the clinical efficacy of domestic ursolic follicle stimulating hormone (u FSH) and Swiss human recombinant human follicle stimulating hormone (r FSH) in the treatment of infertility. Methods A total of 107 infertility patients were divided into A and B groups according to the random number table method. Group A (n = 54) received u FSH treatment and group B (n = 53) received r FSH treatment. The treatment efficiency and ovulation rate , Pregnancy rate, ovarian hyperstimulation syndrome (OHSS) incidence. Results The effective rates of A and B groups were 98.1% and 100.0% respectively, with no significant difference (P> 0.05). Ovulation rate, pregnancy rate, OHSS incidence was no significant difference (P> 0.05). Conclusion Domestic urinary follicle stimulating hormone is an ideal ovulation promoting drug, which has the same effect as human recombinant follicle stimulating hormone in Switzerland, but it is more economical and worthy of promotion in clinical application.